Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2467  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

The value of an acute octreotide suppression test in predicting response to long-term somatostatin analogue therapy in patients with acromegaly

Bandgar T R, Sarathi V, Shivane V, Bansode N, Menon P S, Shah N S

Year : 2010| Volume: 56| Issue : 1 | Page no: 7-11

   This article has been cited by
 
1 Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Annamaria Colao,Renata S. Auriemma,Rosario Pivonello,Leandro Kasuki,Mônica R. Gadelha
Pituitary. 2015;
[Pubmed]  [Google Scholar] [DOI]
2 Diagnosis, treatment and clinical perspectives of acromegaly
Ferdinand Roelfsema,Gerrit van den Berg
Expert Review of Endocrinology & Metabolism. 2015; 10(6): 619
[Pubmed]  [Google Scholar] [DOI]
3 Treatment of acromegaly in the era of personalized and predictive medicine
Manuel Puig Domingo
Clinical Endocrinology. 2015; 83(1): 3
[Pubmed]  [Google Scholar] [DOI]
4 Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide
Baldomero Gonzalez,Guadalupe Vargas,Claudia Ramirez,Silvia Asa,Sonia Cheng,Carolina Sandoval,Moises Mercado
Endocrinología y Nutrición. 2014; 61(10): 523
[Pubmed]  [Google Scholar] [DOI]
5 Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide
Baldomero Gonzalez,Guadalupe Vargas,Claudia Ramirez,Silvia Asa,Sonia Cheng,Carolina Sandoval,Moises Mercado
Endocrinología y Nutrición (English Edition). 2014; 61(10): 523
[Pubmed]  [Google Scholar] [DOI]
6 Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases
Burton, T. and Le Nestour, E. and Bancroft, T. and Neary, M.
Pituitary. 2013; 16(3): 354-362
[Pubmed]  [Google Scholar]
7 Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases
Tanya Burton,Elisabeth Nestour,Tim Bancroft,Maureen Neary
Pituitary. 2013; 16(3): 354
[Pubmed]  [Google Scholar] [DOI]
8 The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases
M. Wang,C. Mou,M. Jiang,L. Han,S. Fan,C. Huan,X. Qu,T. Han,Y. Qu,G. Xu
European Journal of Endocrinology. 2012; 166(5): 797
[Pubmed]  [Google Scholar] [DOI]
9 The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: Clinical analysis of 279 cases
Wang, M. and Mou, C. and Jiang, M. and Han, L. and Fan, S. and Huan, C. and Qu, X. and Han, T. and Qu, Y. and Xu, G.
European Journal of Endocrinology. 2012; 166(5): 797-802
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow